Among Antidiabetic Drugs, SGLT2 Inhibitors Linked to the Lowest Dementia Risk in T2DM Tags SGLT-2 Inhibitor Read more about Among Antidiabetic Drugs, SGLT2 Inhibitors Linked to the Lowest Dementia Risk in T2DM
SGLT2 Inhibitors Linked to Consistent Cardioprotection Regardless of Revascularization Status Tags SGLT-2 Inhibitor Read more about SGLT2 Inhibitors Linked to Consistent Cardioprotection Regardless of Revascularization Status
Additive Benefits Seen with SGLT2 and GLP-1 Combination Therapy in Type 2 Diabetes Tags SGLT-2 Inhibitor Read more about Additive Benefits Seen with SGLT2 and GLP-1 Combination Therapy in Type 2 Diabetes
Nimacimab Shows Favorable Safety and Early Metabolic Effects in MAFLD Read more about Nimacimab Shows Favorable Safety and Early Metabolic Effects in MAFLD
Baricitinib Preserves Beta Cell Function in Young Adults With Recent-Onset T1D Read more about Baricitinib Preserves Beta Cell Function in Young Adults With Recent-Onset T1D
Dapagliflozin Reduces Renal Glucose Uptake and Preserves Kidney Function in Type 2 Diabetes Tags SGLT-2 Inhibitor Read more about Dapagliflozin Reduces Renal Glucose Uptake and Preserves Kidney Function in Type 2 Diabetes
SGLT2 Inhibitor Use After 80 Linked to Higher Discontinuation in Type 2 Diabetes Tags SGLT-2 Inhibitor Read more about SGLT2 Inhibitor Use After 80 Linked to Higher Discontinuation in Type 2 Diabetes
SGLT2 Inhibitors Linked to Higher Phimosis Risk in Men with Type 2 Diabetes Tags SGLT-2 Inhibitor Read more about SGLT2 Inhibitors Linked to Higher Phimosis Risk in Men with Type 2 Diabetes
SGLT2 Inhibitor Use Soars in Older Adults With Frailty in the UK Tags SGLT-2 Inhibitor Read more about SGLT2 Inhibitor Use Soars in Older Adults With Frailty in the UK
Once-Weekly GZR4 Shows Superior Glycemic Control Compared to Daily Insulin Degludec Read more about Once-Weekly GZR4 Shows Superior Glycemic Control Compared to Daily Insulin Degludec